PT  - JOURNAL ARTICLE
AU  - Dofash, Lein N.H.
AU  - Monahan, Gavin
AU  - Servián-Morilla, Emilia
AU  - Rivas, Eloy
AU  - Faiz, Fathimath
AU  - Sullivan, Patricia
AU  - Oates, Emily
AU  - Clayton, Joshua
AU  - Taylor, Rhonda L.
AU  - Davis, Mark R.
AU  - Beilharz, Traude
AU  - Laing, Nigel G.
AU  - Cabrera-Serrano, Macarena
AU  - Ravenscroft, Gianina
TI  - A <em>KLHL40</em> 3’ UTR splice-altering variant causes milder NEM8, an under-appreciated disease mechanism
AID  - 10.1101/2022.08.08.22278402
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.08.08.22278402
4099  - http://medrxiv.org/content/early/2022/08/10/2022.08.08.22278402.short
4100  - http://medrxiv.org/content/early/2022/08/10/2022.08.08.22278402.full
AB  - Nemaline myopathy 8 (NEM8) is typically a severe autosomal recessive disorder associated with variants in the kelch-like family member 40 gene (KLHL40). Common features include fetal akinesia, fractures, contractures, dysphagia, respiratory failure, and neonatal death. Here, we describe a man in his 20s with relatively mild NEM8. He presented with hypotonia and bilateral femur fractures at birth, later developing bilateral Achilles’ contractures, scoliosis, and elbow and knee contractures. He had walking difficulties throughout childhood and became wheelchair bound during adolescence after prolonged immobilisation. Muscle MRI during adolescence indicated prominent fat replacement in his pelvic girdle, posterior compartments of thighs, and vastus intermedius. Muscle biopsy revealed nemaline bodies and intranuclear rods. RNA sequencing and western blotting of patient skeletal muscle indicated significant reduction in KLHL40 mRNA and protein respectively. Using gene panel screening, exome sequencing and RNA sequencing, we identified compound heterozygous variants in KLHL40; a truncating 10.9 kb deletion in trans with a likely pathogenic variant (c.*152G>T) in the 3’ untranslated region (UTR). Computational tools SpliceAI and Introme predicted the c.*152G>T variant created a cryptic donor splice site. RNA-seq and in vitro analyses indicated that the c.*152G>T variant induces multiple de novo splicing events that likely provoke nonsense mediated decay of KLHL40 mRNA explaining the loss of mRNA expression and protein abundance in the patient. Analysis of 3’ UTR variants in ClinVar suggests SNPs that introduce aberrant 3’ UTR splicing may be underrecognised in Mendelian disease. We encourage consideration of this mechanism during variant curation.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by an Australian NHMRC Investigator Grant (APP2007769), Fellowship (APP1117510) and Ideas Grant (APP2002640). The study was supported by an Australian Government Research Training Program (RTP) Scholarship, as well as resources provided by the Pawsey Supercomputing Centre with funding from the Australian Government and the Government of Western Australia.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Human Research Ethics Committee of University of Western Australia gave ethical approval for this work. The Human Research Ethics Office of Curtin University gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the study are available upon reasonable request.IGVIntegrative Genomics ViewerNEM8nemaline myopathy 8RT-PCRreverse transcriptase polymerase chain reaction